IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and ...

IM Cannabis Corp (NASDAQ:IMCC) experienced extraordinary growth in the German market following partial legalization in April 2024. The company reduced operating expenses by 53% since 2022 ...

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3 International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial ...

Short interest in IM Cannabis Corp (NASDAQ:IMCC) decreased during the last reporting period, falling from 16.36K to 6.46K. This put 0.25% of the company's publicly available shares short.

IM Cannabis Corp (NASDAQ:IMCC) experienced extraordinary growth in the German market following partial legalization in April 2024. The company reduced operating expenses by 53% since 2022, with a ...